Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
Fig 4
Fits (red lines) to the acute phase viral loads of the ten untreated macaques in Nishimura et al. [10] obtained by simultaneously fitting our model (Eqs 13–20) to V, A1 and A2 across all macaques. Methods for the fitting procedure. The best-fit parameter estimates are in S2 Table.